Riskpilot← Back to searchSign inGet full accessDocWijk AB
ABActiveOrg 5591293484Violinvägen 36Hospital activities · NACE 8610Est. 20171 employees
Revenue 2025
SEK 221K
+180% vs 2024
EBITDA margin
88.7%
+256% vs 2024
Equity ratio
80.4%
Financial strength
Net profit 2025
SEK 156K
+255% vs 2024
| Revenue | SEK 221K | +180% |
| EBITDA | SEK 196K | +256% |
| Net profit | SEK 156K | +255% |
| Total assets | SEK 260K | +145% |
| Equity | SEK 209K | +103% |
| Employees | 1 | — |
Legal name
DocWijk AB
Org number
5591293484
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
16 oktober 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultuppdrag inom hälso och sjukvård. Administrativt arbete inom hälso och sjukvård. Konsulttjänster till företag gällande organisation, administration och affärsutveckling samt hantering av värdepapper och därmed förenlig verksamhet.
Address
Violinvägen 36
Email
johanna.wijk@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 202 | 231 | 254 | 79 | 221 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 168 | 217 | 205 | 55 | 196 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 168 | 217 | 205 | 55 | 196 |
| Net financials | — | — | — | — | — |
| Profit before tax | 169 | 217 | 205 | 55 | 196 |
| Tax | −35 | −45 | −42 | −11 | −40 |
| Net profit | 134 | 172 | 163 | 44 | 156 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 259 | 311 | 304 | 106 | 260 |
| Equity | 200 | 247 | 239 | 103 | 209 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 60 | 64 | 65 | 3 | 50 |
| Total debt | 60 | 64 | 65 | 3 | 50 |
EBITDA margin
88.7%
This company
15.8%
Market median
+461% vs market
20212025
Equity ratio
80.4%
This company
38.2%
Market median
+110% vs market
20212025
Return on equity
74.6%
This company
18.4%
Market median
+305% vs market
20212025
Net profit margin
70.6%
This company
8.1%
Market median
+772% vs market
20212025
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20212025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DocWijk AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Helge Rönnow | Deputy Board Member | 0 companies |
| Johanna Margareta Wijk | Board of Directors | 0 companies |